Nova Anchora Revenue
Biotechnology Research • • 1-10 Employees
$
Nova Anchora revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Nova Anchora
Jason Bhardwaj
CEO
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Nova Anchora Email Formats
Nova Anchora uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@vikingglobal.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@vikingglobal.com | 100% |
About Nova Anchora
Biopharmaceutical company with technology and IP licensed from Stanford University, developing a protein therapy for epidermolysis bullosa (EB), a rare genetic skin disease
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Nova Anchora has 1 employees across 1 departments.
Departments
Number of employees
Hungary
Netherlands
United Kingdom
Frequently asked questions
Nova Anchora is located in XX.
Nova Anchora generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
Nova Anchora has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Nova Anchora has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
